The Centers for Medicare & Medicaid Services recently issued guidance further clarifying the steps for determining whether a laboratory qualifies as an “applicable laboratory” under a final rule implementing changes to the Medicare clinical laboratory fee schedule, which take effect Jan. 1, 2018. The guidance also clarifies what data applicable laboratories and reporting entities must collect and report to CMS; the data collection and reporting periods; and the implementation schedule. Additional information on the data collection system and advanced diagnostic laboratory tests will be issued through separate guidance, CMS said.  For more on the final rule, see the recent AHA Regulatory Advisory for members.

Related News Articles

Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
President Trump yesterday named Eric Hargan as Acting Secretary of Health and Human Services. Confirmed as HHS deputy secretary last week, Hargan previously…
Headline
Hospitals generally support the proposed cancellation of the cardiac and Surgical Hip and Femur Fracture Treatment bundling program and Comprehensive Care for…
Headline
Twenty-three organizations, including the AHA, Friday urged the Centers for Medicare & Medicaid Services to suspend implementation of new draft Medicare…
Headline
The Centers for Medicare & Medicaid Services has identified the first clinicians eligible to participate in 2018 advanced alternative payment models, based…
Headline
The U.S. Senate this week voted 57-38 to confirm as Health and Human Services Deputy Secretary Eric Hargan, an attorney and shareholder in the health care…